Skip to main content
Premium Trial:

Request an Annual Quote

DNAPrint Genomics Lands $2 Million in Additional Funding

NEW YORK, June 18 - DNAPrint Genomics received a commitment for $2 million in additional funding to be paid over 12 months, the company said Monday. 

The funding, from Sarasota, Fla.-based Tampa Bay Financial, a venture capital firm, will be paid out in monthly increments beginning July 15. 

Last year, Tampa Bay Financial contributed $1 million to DNAPrint Genomics population genetics efforts, and brought the company public in July, 2000, through a reverse merger, said Craig Hall, the director of corporate analysis at the fund.

Tampa Bay Financial decided to fund the company again, Hall said, because DNAPrint Genomics, also of Sarasota, Fla., "has achieved their milestones," Hall told GenomeWeb. The company has written proprietary software that draws associations between patients' genetic make-up and their drug response, as well as built out the company's bioinformatics team. 

The bioinformatics staff is made up of 14 people, Hall noted, with half having PhDs.

Hall said the $2 millon would be equivalent to approximately $166,000 per month over one year, and would match DNAPrint Genomics' burn rate. Hall also said that DNAPrint Genomics had secured an additional $600,000 in private placement funds.


The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.